Medtronic's insulin pump recall gets FDA's highest-risk label

Mon, 07/15/2013 - 9:59am
Mass Device

U.S. healthcare regulators put their highest-risk Class I label on Medtronic's Paradigm insulin infusion pump recall.

Medtronic logo



Medtronic informed patients, healthcare providers and pharmacies in Canada of the potential problem, to explain how to avoid it, according to the Brampton Guardian.


Share this Story

The password field is case sensitive.